Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
By keeping hydrated, you help your body work efficiently to clear out unwanted elements, which is beneficial in the lead-up to a drug test
Eligibility criteria for NHS-funded GLP-1 treatment for weight management include: For semaglutide (Wegovy): BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity For liraglutide (Saxenda): Similar BMI criteria as defined in NICE TA664 Evidence of previous weight management attempts through lifestyle modification Treatment must be initiated within specialist weight management services (Tier 3) Time-limited use as specified in the relevant NICE guidance The referral pathway typically involves: Initial GP consultation: Discuss weight concerns, document BMI and comorbidities, and review previous weight management efforts Tier 2/3 weight management services: Many areas require participation in structured lifestyle programmes before pharmacological intervention Specialist assessment: Referral to specialist weight management services for treatment initiation Ongoing monitoring: Regular review to assess response, tolerability, and continuation criteria Treatment continuation requires achieving the weight loss thresholds specified in the product-specific NICE guidance and SmPCs
Pestic Biochem Physiol 104:5864
A short course of GLP-1RA treatment not only promotes weight loss but also appears to redistribute fat deposits, which may help improve cardiovascular risk in patients with type 2 diabetes [50]
Healthcare providers offer personalized guidance on the benefits and risks of treatment, safe alcohol consumption, potential medication adjustments, and strategies to minimize risks
Oxidative stress and endothelial dysfunction in sepsis and acute inflammation
)
